Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;97(6):615-635.
doi: 10.1159/000543156. Epub 2025 Jan 30.

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring

Martin Tauschmann  1 , Roque Cardona-Hernandez  2 , Daniel J DeSalvo  3 , Korey Hood  4 , Dmitry N Laptev  5 , Anna Lindholm Olinder  6   7 , Benjamin J Wheeler  8   9 , Carmel E Smart  10   11
Affiliations
Review

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring

Martin Tauschmann et al. Horm Res Paediatr. 2024.

Abstract

The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind glucose monitoring, and its role in glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents. The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind glucose monitoring, and its role in glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.

Keywords: Children; Diabetes; Glucose monitoring; Sensor.

PubMed Disclaimer

Conflict of interest statement

M.T.: speaker honoraria from Eli Lilly and Ypsomed and advisory boards for Abbott and Sanofi. R.C.-H.: speaker honoraria from Novo-Nordisk and Sanofi and advisory boards for Dexcom. D.J.D.: consultant for Insulet and Dexcom. K.H.: consulting fees from Havas Health, Sanofi, and Cecelia Health. D.N.L.: speaker honoraria from Abbott and Sanofi and advisory boards for Abbott and Sanofi. A.L.O.: speaker honoraria from Rubin Medical. B.J.W.: speaker honoraria from Dexcom and Medtronic. C.E.S.: speaker honoraria from Medtronic and Eli Lilly and advisory boards for Abbott.

Figures

Fig. 1.
Fig. 1.
CGM technology plays a pivotal role in diabetes management.
See this image and copyright information in PMC

References

    1. Cardona-Hernandez R, Schwandt A, Alkandari H, Bratke H, Chobot A, Coles N, et al. . Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes. Data from the International pediatric registry SWEET. Diabetes Care. 2021;44(5):1176–84. - PubMed
    1. Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, et al. . Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146–56. - PubMed
    1. Seidu S, Kunutsor SK, Ajjan RA, Choudhary P. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care. 2024;47(1):169–79. - PubMed
    1. Klonoff DC, Nguyen KT, Xu NY, Gutierrez A, Espinoza JC, Vidmar AP. Use of continuous glucose monitors by people without diabetes: an idea whose time has come? J Diabetes Sci Technol. 2023;17(6):1686–97. - PMC - PubMed
    1. Wilson DM, Pietropaolo SL, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, et al. . CGM metrics identify dysglycemic States in participants from the TrialNet pathway to prevention study. Diabetes Care. 2023;46(3):526–34. - PMC - PubMed